Google DeepMind co‑founder Mustafa Suleyman placed on leave

Mustafa Suleyman, the co‑founder of Google’s DeepMind AI lab, was put on leave in August 2019 following undisclosed controversy surrounding projects he led [1]. Suleyman, who heads DeepMind’s “applied” division that turns research into health, energy and other practical uses, has been a public face for the lab, regularly speaking to officials about AI’s promise and its ethical safeguards.

The leave comes after a turbulent decade for DeepMind. Founded in 2010 with CEO Demis Hassabis, the lab was bought by Google for £400 million (about $486 million) in 2014, launching an expensive talent race in Silicon Valley [1]. DeepMind’s health arm, built into a 100‑person team under Suleyman, drew sharp criticism when the UK’s data watchdog found that the Royal Free Hospital had illegally shared 1.6 million patient records with the lab in 2017 [1]. Suleyman apologized then, and the health unit was later folded into Google Health, stripping him of day‑to‑day control [1].

Beyond the health scandal, Suleyman served on internal Google panels reviewing AI ethics, including a group formed after a Pentagon AI contract controversy [1]. The lack of a public explanation for his leave fuels speculation about internal disagreements over DeepMind’s direction and governance.

Suleyman’s absence leaves a gap in DeepMind’s leadership at a time when the lab faces mounting pressure to balance rapid AI advances with ethical oversight. How Google navigates this balance—and whether the pause signals deeper strategic shifts—remains to be seen.